1. miR-384 suppressed renal cell carcinoma cell proliferation and migration through targeting RAB23
- Author
-
Hongmei Guan, Kunxiang Wu, Xianzhe Yin, Lihua Yan, and Feng Du
- Subjects
0301 basic medicine ,Cell growth ,Cell migration ,Cell Biology ,Biology ,Cell cycle ,urologic and male genital diseases ,medicine.disease ,Biochemistry ,female genital diseases and pregnancy complications ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Downregulation and upregulation ,Tumor progression ,Renal cell carcinoma ,030220 oncology & carcinogenesis ,microRNA ,Cancer research ,medicine ,Ectopic expression ,neoplasms ,Molecular Biology - Abstract
microRNAs (miRNAs) are noncoding, short, and endogenous RNAs that play crucial roles in tumor progression at the post-transcriptional level. Here, we studied the role of miR-384 in the pathogenesis of renal cell carcinoma (RCC). We demonstrated that miR-384 expression was downregulated in the RCC specimens compared with nontumor specimens. Moreover, we showed that RAB23 expression was upregulated in the RCC tissues compared with nontumor tissues. Furthermore, we demonstrated that low expression of miR-384 was correlated with high levels of RAB23 in RCC tissues. We also demonstrated that the RAB23 was a direct target gene of miR-384 in RCC cells. In addition, overexpression of miR-384 suppressed RCC cell proliferation, cell cycle, and cell migration. Furthermore, ectopic expression of RAB23 promoted RCC cell proliferation, cell cycle, and cell migration. These data suggested that miR-384 played a tumor suppressor microRNA in the development of RCC partly through inhibiting RAB23 expression.
- Published
- 2018